๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

โœ Scribed by Mekhail, T. M.

Book ID
125508986
Publisher
American Society of Clinical Oncology
Year
2005
Tongue
English
Weight
254 KB
Volume
23
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prognostic factors for survival in previ
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M, Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.: J Clin Oncol 2004;22:454โ€“63
โœ Donald L. Trump ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 21 KB
317 Prognostic influence of chromophobe
317 Prognostic influence of chromophobe subtype and sarcomatoid dedifferentiation in patients with renal cell carcinoma and impact of clinical and histopathological parameters on disease-specific survival in patients with collecting duct renal cell carcinoma (CDRCC): Results of comprehensive analyses of the CORONA and SATURN databases and development of a disease-specific risk-model for CDRCC patients
โœ Brookman-May, S.D.; Ficarra, V.; Shariat, S.; Zigeuner, R.; Chromecki, T.; Cindo ๐Ÿ“‚ Article ๐Ÿ“… 2014 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 115 KB